Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D T Barrett

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
Virology|April 13, 2005
Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strainsLi Li, Alan D T Barrett, David W C Beasley
Vaccine|June 29, 2011
The development of Dengue vaccines. IntroductionBeth-Ann Coller, Alan D T Barrett, Stephen J Thomas
Vaccine|November 25, 2015
IntroductionBeth-Ann Coller, Alan D T Barrett, Stephen J Thomas
Plos Pathogens|May 22, 2007
Out of Africa: a molecular perspective on the introduction of yellow fever virus into the AmericasJuliet E Bryant, Edward C Holmes, Alan D T Barrett
The Journal of General Virology|December 3, 2010
Genetic characterization of Japanese encephalitis virus genotype II strains isolated from 1951 to 1978Amy J Schuh, Robert B Tesh, Alan D T Barrett
Infection and Drug Resistance|November 29, 2023
Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A PerspectiveClairissa A Hansen, J Erin Staples, Alan D T Barrett
Antiviral Research|April 30, 2013
Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done?David W C Beasley, Alan D T Barrett, Robert B Tesh
The Journal of General Virology|May 7, 2010
Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain IIIKiyohiko Matsui, Gregory D Gromowski, Li Li, et al.
NPJ Vaccines|July 14, 2020
Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protectionJ Erin Staples, Alan D T Barrett, Annelies Wilder-Smith, et al.
Vaccine|October 20, 2015
Mouse models of dengue virus infection for vaccine testingVanessa V Sarathy, Gregg N Milligan, Nigel Bourne, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
Virology|April 13, 2005
Differential expression of domain III neutralizing epitopes on the envelope proteins of West Nile virus strainsLi Li, Alan D T Barrett, David W C Beasley
Vaccine|June 29, 2011
The development of Dengue vaccines. IntroductionBeth-Ann Coller, Alan D T Barrett, Stephen J Thomas
Vaccine|November 25, 2015
IntroductionBeth-Ann Coller, Alan D T Barrett, Stephen J Thomas
Plos Pathogens|May 22, 2007
Out of Africa: a molecular perspective on the introduction of yellow fever virus into the AmericasJuliet E Bryant, Edward C Holmes, Alan D T Barrett
The Journal of General Virology|December 3, 2010
Genetic characterization of Japanese encephalitis virus genotype II strains isolated from 1951 to 1978Amy J Schuh, Robert B Tesh, Alan D T Barrett
Infection and Drug Resistance|November 29, 2023
Fractional Dosing of Yellow Fever Live Attenuated 17D Vaccine: A PerspectiveClairissa A Hansen, J Erin Staples, Alan D T Barrett
Antiviral Research|April 30, 2013
Resurgence of West Nile neurologic disease in the United States in 2012: what happened? What needs to be done?David W C Beasley, Alan D T Barrett, Robert B Tesh
The Journal of General Virology|May 7, 2010
Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain IIIKiyohiko Matsui, Gregory D Gromowski, Li Li, et al.
NPJ Vaccines|July 14, 2020
Review of data and knowledge gaps regarding yellow fever vaccine-induced immunity and duration of protectionJ Erin Staples, Alan D T Barrett, Annelies Wilder-Smith, et al.
Vaccine|October 20, 2015
Mouse models of dengue virus infection for vaccine testingVanessa V Sarathy, Gregg N Milligan, Nigel Bourne, et al.
Pageof 20